1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > A 28-Country Survey of the European Nucleic Acid Testing (NAT) Market: Sales Forecasts and Supplier Shares--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Competitive Strategies, Instrumentation and Technology Review, Opportuniti

A 28-Country Survey of the European Nucleic Acid Testing (NAT) Market: Sales Forecasts and Supplier Shares--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Competitive Strategies, Instrumentation and Technology Review, Opportuniti

  • February 2016
  • -
  • Venture Planning Group
  • -
  • 1150 pages

Summary

Table of Contents

This new 28-country survey from VPGMarketResearch.com contains over 1,150 pages, 213 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.


Highlights


- Supplier sales and market shares in major countries


- Five-year test volume and sales forecasts


- Strategic profiles of market players and start-up firms developing innovative technologies and products


- Emerging technologies


- Review of molecular diagnostic analyzers


- Specific product and business opportunities for instrument and consumable suppliers


Rationale


The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.


In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.


Geographic Coverage


Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK


Market Segmentation Analysis


- Sales and market shares of key suppliers of molecular diagnostic reagent kits and components in major markets.


- Five-year test volume and sales forecasts for major applications, including:


     - Infectious Diseases         - Forensic Testing

     - Cancer                             - Paternity Testing/HLA Typing

     - Genetic Diseases             - Others


- Five-year test volume and sales projections for over 30 NAT assays.


- Analysis of the sequencing market, including:


- Industrial - Academic - Government - Commercial


- Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.


Product/Technology Review


- Comparison of leading molecular diagnostic ;analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.


- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:


- PCR     - bDNA

- SDA     - NASBA

- TMA    - SSSR, and others

- LCR


- Universities and research centers developing new molecular diagnostic technologies and products.


Competitive Assessments


- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.


- Companies developing and marketing molecular diagnostics products, by test and application.


Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


- Business planning issues and concerns.


Contains 1,150 pages and 213 tables

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


Download Unlimited Documents from Trusted Public Sources

Mental Health Statistics in the US

  • April 2017
    6 pages
  • Mental Health  

  • United States  

View report >

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Mental Health Statistics in the US - Forecast

  • April 2017
    3 pages
  • Mental Health  

    Neurological Di...  

  • United States  

View report >

Obesity Statistics

7 days ago

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.